WO2001068079A3 - Viscoelastics for use in middle ear surgery - Google Patents

Viscoelastics for use in middle ear surgery Download PDF

Info

Publication number
WO2001068079A3
WO2001068079A3 PCT/US2001/008064 US0108064W WO0168079A3 WO 2001068079 A3 WO2001068079 A3 WO 2001068079A3 US 0108064 W US0108064 W US 0108064W WO 0168079 A3 WO0168079 A3 WO 0168079A3
Authority
WO
WIPO (PCT)
Prior art keywords
viscoelastics
middle ear
ear surgery
surgical
surgery
Prior art date
Application number
PCT/US2001/008064
Other languages
French (fr)
Other versions
WO2001068079A2 (en
Inventor
Masoud R Jafari
Uday Doshi
Original Assignee
Alcon Universal Ltd
Masoud R Jafari
Uday Doshi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/857,543 priority Critical patent/US6632423B2/en
Application filed by Alcon Universal Ltd, Masoud R Jafari, Uday Doshi filed Critical Alcon Universal Ltd
Priority to MXPA02008966A priority patent/MXPA02008966A/en
Priority to CA002402652A priority patent/CA2402652C/en
Priority to AU2001247410A priority patent/AU2001247410B2/en
Priority to AT01920347T priority patent/ATE466583T1/en
Priority to AU4741001A priority patent/AU4741001A/en
Priority to JP2001566643A priority patent/JP4746244B2/en
Priority to EP01920347A priority patent/EP1267894B1/en
Priority to DE60142031T priority patent/DE60142031D1/en
Priority to BR0109162-0A priority patent/BR0109162A/en
Publication of WO2001068079A2 publication Critical patent/WO2001068079A2/en
Publication of WO2001068079A3 publication Critical patent/WO2001068079A3/en
Priority to HK03100886.4A priority patent/HK1048765A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/14—Materials or treatment for tissue regeneration for ear reconstruction or ear implants, e.g. implantable hearing aids

Abstract

Disclosed are viscoelastic compositions and methods of their use in surgical and non-surgical packing and in effecting drug delivery, especially in conjunction with trauma to or disorders of the ear.
PCT/US2001/008064 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery WO2001068079A2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AU4741001A AU4741001A (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
MXPA02008966A MXPA02008966A (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery.
CA002402652A CA2402652C (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
AU2001247410A AU2001247410B2 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
AT01920347T ATE466583T1 (en) 2000-03-14 2001-03-14 VISCOELASTIC SUBSTANCES FOR USE IN MIDDLE EAR SURGERY
US09/857,543 US6632423B2 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
JP2001566643A JP4746244B2 (en) 2000-03-14 2001-03-14 Viscous agent for use in middle ear surgery
BR0109162-0A BR0109162A (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
DE60142031T DE60142031D1 (en) 2000-03-14 2001-03-14 VISCOELASTIC SUBSTANCES FOR USE IN MID-EAR OPERATIONS
EP01920347A EP1267894B1 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
HK03100886.4A HK1048765A1 (en) 2000-03-14 2003-02-07 Viscoelastics for use in middle ear surgery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18917900P 2000-03-14 2000-03-14
US60/189,179 2000-03-14

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09/857,543 A-371-Of-International US6632423B2 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery
US10/293,094 Continuation-In-Part US20030086899A1 (en) 2000-03-14 2002-11-13 Chondroitin sulfate containing viscoelastics for use in treating joints

Publications (2)

Publication Number Publication Date
WO2001068079A2 WO2001068079A2 (en) 2001-09-20
WO2001068079A3 true WO2001068079A3 (en) 2002-07-25

Family

ID=22696258

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/008064 WO2001068079A2 (en) 2000-03-14 2001-03-14 Viscoelastics for use in middle ear surgery

Country Status (13)

Country Link
US (1) US6632423B2 (en)
EP (1) EP1267894B1 (en)
JP (1) JP4746244B2 (en)
AT (1) ATE466583T1 (en)
AU (2) AU4741001A (en)
BR (1) BR0109162A (en)
CA (1) CA2402652C (en)
DE (1) DE60142031D1 (en)
ES (1) ES2343402T3 (en)
HK (1) HK1048765A1 (en)
MX (1) MXPA02008966A (en)
WO (1) WO2001068079A2 (en)
ZA (1) ZA200206696B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
CA2441352C (en) * 2001-02-15 2010-05-25 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7363928B2 (en) 2001-12-21 2008-04-29 Alcon, Inc. Dilution resistant viscoelastic compositions
DK1455750T3 (en) * 2001-12-21 2006-04-10 Alcon Inc Viscoelelastic ophthalmic compositions comprising hyaluronic acid and chondroitin sulfate
US20040118414A1 (en) 2002-12-20 2004-06-24 Shah Mandar V Surface modified viscoelastics for ocular surgery
US7820194B2 (en) 2001-12-21 2010-10-26 Alcon, Inc. Combinations of viscoelastics for use during surgery
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
US20060003964A1 (en) * 2004-06-30 2006-01-05 Shah Mandar V Dilution resistant viscoelastic compositions
WO2006085987A2 (en) * 2004-07-09 2006-08-17 University Of Iowa Research Foundation Rna interference in respiratory epitheial cells
US8313762B2 (en) * 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
WO2009132228A1 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Chitosan-containing protective composition
JP5738753B2 (en) 2008-04-24 2015-06-24 メドトロニック，インコーポレイテッド Rehydratable polysaccharide particles and sponges
AU2009240512B2 (en) * 2008-04-24 2014-07-10 Medtronic, Inc. Protective gel based on chitosan and oxidized polysaccharide
AU2009240509B2 (en) 2008-04-24 2014-08-21 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
US8030297B2 (en) 2008-05-14 2011-10-04 Otonomy, Inc. Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
CN102112112A (en) * 2008-07-21 2011-06-29 奥德纳米有限公司 Controlled release antimicrobial compositions and methods for treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US10806833B1 (en) 2009-05-11 2020-10-20 Integra Lifesciences Corporation Adherent resorbable matrix
US9326943B1 (en) 2009-06-23 2016-05-03 Sandra M. Skovlund Biodegradable prosthesis
US8876795B2 (en) * 2011-02-02 2014-11-04 The Charles Stark Draper Laboratory, Inc. Drug delivery apparatus
DK2596796T3 (en) 2011-11-24 2014-01-27 Quimera Ingenieria Biomedica S L Complex obtained from hyaluronic acid or a salt thereof and chondroitin sulfate mixtures
KR20160047490A (en) 2013-08-27 2016-05-02 오토노미, 인코포레이티드 Treatment of pediatric otic disorders
CN105903087A (en) * 2015-12-14 2016-08-31 上海其胜生物制剂有限公司 Preparation method of viscoelastic agent with cohesiveness and dispersivity
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa
CN106821980B (en) * 2017-02-17 2019-10-18 成都博创必成生物技术有限公司 A kind of nasal mist and preparation method thereof and biological barrier film
MX2022001374A (en) 2019-07-31 2022-03-17 Astellas Pharma Inc Pharmaceutical composition for otic administration.
CN114224609B (en) * 2021-12-14 2024-01-30 曹佩培 Middle ear/eustachian tube anti-adhesion film and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341007A2 (en) * 1988-05-02 1989-11-08 Project Hear Surgical adhesive material
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5501706A (en) * 1994-11-29 1996-03-26 Wildflower Communications, Inc. Medical implant structure and method for using the same
WO1997041899A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
WO1998026777A1 (en) * 1996-12-17 1998-06-25 Alcon Laboratories, Inc. Ophtalmic viscoelastic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5166331A (en) 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US6051560A (en) 1986-06-26 2000-04-18 Nestle S.A. Chrondroitin sulfate/sodium hyaluronate composition
US5273056A (en) * 1992-06-12 1993-12-28 Alcon Laboratories, Inc. Use of combinations of viscoelastics during surgery
KR100246016B1 (en) 1993-04-30 2000-04-01 피르 포겔 Synthetic viscoelastic material for ophthalmic applications
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341007A2 (en) * 1988-05-02 1989-11-08 Project Hear Surgical adhesive material
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5501706A (en) * 1994-11-29 1996-03-26 Wildflower Communications, Inc. Medical implant structure and method for using the same
WO1997041899A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
WO1998026777A1 (en) * 1996-12-17 1998-06-25 Alcon Laboratories, Inc. Ophtalmic viscoelastic compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KRUPALA JAMES L ET AL: "The efficacy of hyaluronic acid foam as a middle ear packing agent in experimental tympanoplasty.", AMERICAN JOURNAL OF OTOLOGY, vol. 19, no. 5, 1998, pages 546 - 550, XP001055587, ISSN: 0192-9763 *
ROSIAK J M ET AL: "Radiation formation of hydrogels for biomedical purposes. Some remarks and comments", RADIATION PHYSICS AND CHEMISTRY, ELSEVIER SCIENCE PUBLISHERS BV., AMSTERDAM, NL, vol. 46, no. 2, 1 August 1995 (1995-08-01), pages 161 - 168, XP004051385, ISSN: 0969-806X *

Also Published As

Publication number Publication date
JP2003534036A (en) 2003-11-18
CA2402652C (en) 2008-11-18
HK1048765A1 (en) 2003-04-17
MXPA02008966A (en) 2003-02-12
US6632423B2 (en) 2003-10-14
ZA200206696B (en) 2003-08-21
EP1267894B1 (en) 2010-05-05
AU2001247410B2 (en) 2005-05-12
US20020169142A1 (en) 2002-11-14
JP4746244B2 (en) 2011-08-10
BR0109162A (en) 2005-01-11
ATE466583T1 (en) 2010-05-15
WO2001068079A2 (en) 2001-09-20
AU4741001A (en) 2001-09-24
CA2402652A1 (en) 2001-09-20
ES2343402T3 (en) 2010-07-30
DE60142031D1 (en) 2010-06-17
EP1267894A2 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
WO2001068079A3 (en) Viscoelastics for use in middle ear surgery
AU2003273276A1 (en) Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
EP1600169A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
WO2005007142A3 (en) Liquid compositions comprising formoterol
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
MXPA03007590A (en) Compositions and methods for enhancing drug delivery across and into ocular tissues.
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
WO2004006858A3 (en) Compounds, compositions, and methods employing same
AU2003289888A1 (en) Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
WO2006054309A3 (en) Debriding composition from bromelain
WO2002069945A3 (en) Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
WO2005009460A3 (en) Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
AU2002232437A1 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
AU2003272903A1 (en) Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
WO2002008222A3 (en) HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
AU2001242130A1 (en) Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
WO2003057187A8 (en) Combinations of viscoelastics for use during surgery
WO2002036096A8 (en) Non-aspirating transitional viscoelastics for use in surgery
AU2002341555A1 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
WO2005115365A3 (en) Pharmaceutical or cosmetic composition comprising mequinol and at least one depigmenting agent
WO2002070537A3 (en) Fusidic acid derivatives
WO2005035746A3 (en) Medical use of tbk-1 or of inhibitors thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 09857543

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN JP MX PL US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN JP MX PL US ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 200206696

Country of ref document: ZA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 566643

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001247410

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2402652

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/008966

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2001920347

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001920347

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001247410

Country of ref document: AU